334 First-in-human study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of oral cp-724, 714, a selective, small molecule inhibitor of her2 in patients with advanced cancer

2004 ◽  
Vol 2 (8) ◽  
pp. 101 ◽  
Author(s):  
P.N. Munster ◽  
A.W. Tolcher ◽  
C.D. Britten ◽  
K. Gelmon ◽  
S. Moulder ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document